Draxis Health Inc /CN/ - Report of Foreign Issuer (6-K)
23 Mai 2008 - 9:10PM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE
COMMISSION
Washington, DC 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE
ISSUER
Pursuant to
Rule 13a-16 or 15-d-16 of
The Securities
Exchange Act of 1934
For May 23,
2008
Commission
File Number 000-17434
DRAXIS HEALTH INC.
(Translation of
registrants name into English)
Suite 4700, TD Bank Tower
Toronto Dominion Centre
Toronto, Ontario M5K 1E6
CANADA
(Address
of principal offices)
Registrant
files annual reports under cover of Form 20-F
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this
report to be signed on its behalf by the undersigned, thereunto duly
authorized.
DRAXIS
HEALTH INC.
|
|
|
By: /s/ Alida Gualtieri
|
General
Counsel & Secretary
|
Dated: May 23, 2008
2
Draxis Health (MM) (NASDAQ:DRAX)
Historical Stock Chart
Von Dez 2024 bis Jan 2025
Draxis Health (MM) (NASDAQ:DRAX)
Historical Stock Chart
Von Jan 2024 bis Jan 2025
Echtzeit-Nachrichten über Draxis Health (MM) (NASDAQ): 0 Nachrichtenartikel
Weitere Draxis Health Inc /CN/ News-Artikel